As of 2025-12-21, the Relative Valuation of Jazz Pharmaceuticals PLC (JAZZ) is (20.70) USD. This relative valuation is based on P/E multiples. With the latest stock price at 166.99 USD, the upside of Jazz Pharmaceuticals PLC based on Relative Valuation is -112.4%.
The range of the Relative Valuation is (163.23) - 191.33 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.9x - 35.6x | 30.6x |
| Forward P/E multiples | 23.6x - 38.4x | 28.9x |
| Fair Price | (163.23) - 191.33 | (20.70) |
| Upside | -197.7% - 14.6% | -112.4% |
| Date | P/E |
| 2025-12-19 | -27.54 |
| 2025-12-18 | -27.38 |
| 2025-12-17 | -27.20 |
| 2025-12-16 | -27.99 |
| 2025-12-15 | -27.96 |
| 2025-12-12 | -27.62 |
| 2025-12-11 | -27.19 |
| 2025-12-10 | -27.21 |
| 2025-12-09 | -26.76 |
| 2025-12-08 | -27.86 |
| 2025-12-05 | -27.99 |
| 2025-12-04 | -27.53 |
| 2025-12-03 | -27.56 |
| 2025-12-02 | -27.49 |
| 2025-12-01 | -28.39 |
| 2025-11-28 | -29.11 |
| 2025-11-26 | -29.18 |
| 2025-11-25 | -29.69 |
| 2025-11-24 | -29.83 |
| 2025-11-21 | -29.18 |
| 2025-11-20 | -28.98 |
| 2025-11-19 | -29.04 |
| 2025-11-18 | -29.77 |
| 2025-11-17 | -28.05 |
| 2025-11-14 | -23.27 |
| 2025-11-13 | -23.37 |
| 2025-11-12 | -22.55 |
| 2025-11-11 | -22.61 |
| 2025-11-10 | -21.97 |
| 2025-11-07 | -21.63 |
| 2025-11-06 | -22.11 |
| 2025-11-05 | -22.63 |
| 2025-11-04 | -22.73 |
| 2025-11-03 | -22.82 |
| 2025-10-31 | -22.70 |
| 2025-10-30 | -22.48 |
| 2025-10-29 | -22.38 |
| 2025-10-28 | -22.78 |
| 2025-10-27 | -22.98 |
| 2025-10-24 | -22.85 |
| 2025-10-23 | -22.79 |
| 2025-10-22 | -22.84 |
| 2025-10-21 | -22.68 |
| 2025-10-20 | -22.24 |
| 2025-10-17 | -22.44 |
| 2025-10-16 | -22.14 |
| 2025-10-15 | -22.40 |
| 2025-10-14 | -22.07 |
| 2025-10-13 | -22.29 |
| 2025-10-10 | -22.33 |